Malignant Peritoneal Neoplasm Completed Phase 3 Trials for Paclitaxel (DB01229)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

IndicationStatusPhase
DBCOND0073968 (Malignant Peritoneal Neoplasm)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02728622Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and TaxaneTreatment